Groundbreaking research identifies a novel pathway where disrupted lipid metabolism in brain immune cells accelerates Alzheimer’s progression. The discovery opens new therapeutic avenues targeting microglial dysfunction.
** A leading neuroscientist proposes Alzheimer’s disease is primarily a disorder of the brain’s immune system, not a brain disease. This revolutionary theory challenges decades of beta-amyloid research and could unlock new treatment possibilities for millions affected by Alzheimer’s worldwide. **CONTENT:**
Alzheimer’s disease may not actually be a brain disease at all, according to groundbreaking new research that challenges decades of scientific consensus. Instead, emerging evidence suggests Alzheimer’s could primarily be a disorder of the immune system within the brain – a paradigm shift that could revolutionize how we understand and treat this devastating condition that affects millions worldwide.
